| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,680 |
6,666 |
$610K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,176 |
4,702 |
$288K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
5,519 |
4,891 |
$133K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
978 |
880 |
$113K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,474 |
1,408 |
$108K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,293 |
1,242 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,198 |
1,157 |
$91K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
650 |
573 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,012 |
1,424 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,200 |
2,046 |
$29K |
| 99215 |
Prolong outpt/office vis |
264 |
234 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
633 |
607 |
$29K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,335 |
2,211 |
$22K |
| 90686 |
|
1,747 |
1,680 |
$20K |
| 90651 |
|
366 |
345 |
$17K |
| 87081 |
|
1,696 |
1,579 |
$12K |
| 92551 |
|
1,205 |
1,141 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
726 |
687 |
$10K |
| 99177 |
|
2,749 |
2,619 |
$10K |
| 96127 |
|
2,088 |
1,957 |
$9K |
| 90670 |
|
481 |
449 |
$9K |
| 90734 |
|
261 |
241 |
$8K |
| 96160 |
|
3,205 |
2,884 |
$6K |
| 99051 |
|
1,132 |
1,029 |
$4K |
| 90698 |
|
249 |
234 |
$4K |
| 99401 |
|
269 |
263 |
$3K |
| 90620 |
|
73 |
72 |
$3K |
| 90633 |
|
201 |
199 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
919 |
859 |
$2K |
| 0001A |
|
61 |
60 |
$2K |
| 90680 |
|
162 |
150 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
58 |
52 |
$2K |
| 86580 |
|
257 |
250 |
$2K |
| 90707 |
|
78 |
77 |
$1K |
| 90716 |
|
53 |
52 |
$1K |
| 99174 |
|
188 |
188 |
$1K |
| 96161 |
|
454 |
396 |
$1K |
| 90744 |
|
92 |
87 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
49 |
43 |
$887.86 |
| 0071A |
|
18 |
18 |
$720.00 |
| 90685 |
|
67 |
66 |
$693.00 |
| 94760 |
|
436 |
361 |
$652.93 |
| 0072A |
|
15 |
15 |
$600.00 |
| 81002 |
|
197 |
171 |
$517.51 |
| 99188 |
|
26 |
26 |
$482.33 |
| 0002A |
|
12 |
12 |
$480.00 |
| 90715 |
|
25 |
25 |
$451.93 |
| A7006 |
Administration set, with small volume filtered pneumatic nebulizer |
49 |
43 |
$303.08 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
65 |
57 |
$225.00 |
| 93000 |
|
14 |
13 |
$161.91 |
| 96156 |
|
77 |
75 |
$159.11 |
| 90461 |
|
48 |
45 |
$125.85 |
| A7015 |
Aerosol mask, used with dme nebulizer |
50 |
44 |
$41.52 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
49 |
43 |
$7.06 |
| 91300 |
|
112 |
101 |
$0.73 |
| 97802 |
|
56 |
52 |
$0.00 |
| 91307 |
|
33 |
33 |
$0.00 |
| 99072 |
|
25 |
25 |
$0.00 |